Our latest publication in @ScienceAdvances is officially out! .Here, we target the NPY/NPY1R signalling axis to lessen metastatic burden of mutant p53-dependent #PancreaticCancer 🔬👩🏼‍🔬.Check it out here: .@GarvanInstitute @Timpson_Lab.

RT @GarvanInstitute: Join us in our mission to save lives and transform the future of pancreatic cancer treatment. 💜. Click here to find ou….

RT @GarvanInstitute: We’re excited to share news from the @ampliatx ACCENT trial: one patient with advanced pancreatic cancer showed no rem….

RT @ampliatx: $ATX | #Amplia has announced that a second patient enrolled in the ACCENT trial has recorded a confirmed complete response (C….

RT @ampliatx: Did you catch this summary of the latest results from Amplia's ACCENT clinical trial in Small Caps this week? Take a look: h….

RT @ampliatx: $ATX UPDATE | #Amplia has today announced that a patient from ACCENT clinical trial in advanced #pancreatic cancer has now re….

RT @ampliatx: #Amplia has made headlines today following the announcement of a “pathological complete response” in an advanced #pancreaticc….

RT @ExtracellMatrix: Integrins provide a bridge between cancer cells and the #ECM, playing a role in every stage of disease progression. 🌉….

RT @ampliatx: $ATX | #Amplia has today announced that trial initiation activities for the planned pancreatic cancer trial in the US have be….

Check out our latest work on @7NewsSydney 🎥.Here, we report on targeting the NPY/NPY1R signalling axis to lessen #PancreaticCancer metastasis🔬👩🏼‍🔬.@GarvanInstitute.Check it out here: .

RT @ANZSCDB: 📢 Hunter Meeting 2025 - Abstract submissions close on Friday 14th February 2025, 5pm AEST!. The Hunter Meeting promises a fabu….

Want to join our lab and contribute to world-class cancer research in Sydney? We are looking for a new research assistant! 🔬🧫 Apply here:

RT @ampliatx: Today - on #WorldCancerDay - we're grateful to our research collaborators, whose expertise and dedication make our clinical t….

RT @TheCesareLab: 1/Delighted to announce the newest paper from our lab, “Homologous recombination promotes non-immunogenic mitotic cell de….

RT @GarvanInstitute: Congratulations to Dr Brooke Pereira on receiving a Fulbright Future Scholarship. Her work in pancreatic cancer resear….

RT @CCB_Research: Congratulations to CCB’s @dr_phil_gregory, @QuentenSchwarz and @TMEM_Samuel, who have been awarded @NHMRC Ideas Grant fun….

RT @brooke_pereira_: I'm very pleased to share that I have received a NHMRC Ideas grant to explore targeting fibrosis in combination with c….

RT @ampliatx: VIDEO | #Amplia CEO & MD Dr Chris Burns and COO Dr Rhiannon Jones discuss the significance of Amplia’s latest clinical data f….

RT @cancerNSW: A $3.75 million grant from the Institute is supporting an innovative ‘personalised medicine framework’ that is giving hope t….

RT @GICancer: Congratulations to Jan Mumford, our well-deserved recipient of the 2024 John Zalcberg AO Award for Excellence in AGITG Resear….